<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04580524</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-20-0655</org_study_id>
    <nct_id>NCT04580524</nct_id>
  </id_info>
  <brief_title>Phasix Mesh Use in Complex Open Ventral Hernias Study</brief_title>
  <official_title>Poly-4-hydroxybutyrate Mesh Versus Current Care of Complex Open Ventral Hernias: A Multi-Center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare clinical and patient centered outcomes of&#xD;
      biosynthetic poly-4-hydroybutyrate meshes versus current care (synthetic polypropylene mesh&#xD;
      or suture) for complex ventral hernia repair. The primary outcome for this study will be&#xD;
      patients who are major complication free at 2 years postoperative. This will be a composite&#xD;
      of hernia recurrence, reoperation, chronic wound complication, or death. Secondary outcomes&#xD;
      include: surgical site occurences such as surgical site infection, seroma, hematoma and skin&#xD;
      dehiscence within 90 days postoperative, emergency room visits withing 90 days postoperative,&#xD;
      days in hospital up to 90 days postoperative, abdominal pain, and change in patient centered&#xD;
      outcomes measured through the modified activities assessment scale (mAAS).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major complication free</measure>
    <time_frame>2 years post-operative</time_frame>
    <description>A composite of hernia recurrence, reoperation, chronic wound complication, or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical site occurrences</measure>
    <time_frame>90 days post-operative</time_frame>
    <description>Surgical site infection, seroma, hematoma, and skin dehiscence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clavien-Dindo complication grade</measure>
    <time_frame>90 days post-operative</time_frame>
    <description>Clavien-Dindo complication grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital duration</measure>
    <time_frame>90 days post-operative</time_frame>
    <description>Days in hospital composed of post-operative length of stay and readmissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency room visits</measure>
    <time_frame>90 days post-operative</time_frame>
    <description>Number of times ER was visited</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Analysis</measure>
    <time_frame>2 years</time_frame>
    <description>Analysis of costs as performed from the healthcare perspective</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative abdominal pain</measure>
    <time_frame>Day of consent and post-operatively at 1 month, 1 year and 2 years</time_frame>
    <description>Measured by the visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient centered outcomes</measure>
    <time_frame>Day of consent and post-operatively at 1 month, 1 year and 2 years</time_frame>
    <description>Abdominal wall health status (AW-HS) measured through the modified activities assessment scale (mAAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">222</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Phasix Mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phasix mesh will be used in the repair of the hernia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Current Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The hernia will be repaired with either synthetic mesh or suture repair, as determined by the operating surgeon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repair of ventral hernia using biologic mesh</intervention_name>
    <description>Ventral hernia will be repaired using biologic mesh</description>
    <arm_group_label>Phasix Mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repair of ventral hernia using suture repair or synthetic mesh</intervention_name>
    <description>Ventral hernia will be repaired using the current treatment methods</description>
    <arm_group_label>Current Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (18 years or older) with a complex ventral hernia scheduled for repair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients likely to die within 3 years (cirrhosis, terminal cancer, surgeon judgement)&#xD;
&#xD;
          -  Unlikely to follow-up (live out of state, unable to be reached by phone or email)&#xD;
&#xD;
          -  Non-English and non-Spanish speakers&#xD;
&#xD;
          -  Pregnant or breast-feeding patients&#xD;
&#xD;
          -  Allergies/hypersensitivities to tetracycline hydrochloride and kanamycin sulfate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie Holihan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTHealth</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Holihan, MD</last_name>
    <phone>713-500-7188</phone>
    <email>Julie.L.Holihan@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Debbie F Lew, MPH</last_name>
    <phone>713-566-5097</phone>
    <email>Debbie.F.Lew@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lyndon B. Johnson General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie Holihan, MD</last_name>
      <phone>713-500-7188</phone>
      <email>Julie.L.Holihan@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Debbie F Lew, MPH</last_name>
      <phone>713-566-5097</phone>
      <email>Debbie.F.Lew@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Hospital-Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie Holihan, MD</last_name>
      <phone>713-500-7188</phone>
      <email>Julie.L.Holihan@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Debbie F Lew, MPH</last_name>
      <phone>713-566-5097</phone>
      <email>Debbie.F.Lew@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 2, 2020</study_first_submitted>
  <study_first_submitted_qc>October 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Julie Holihan</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery-Clinical</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

